Retrospective evaluation of retinopathy of prematurity screening in the fifty-nine patients

Öz

Purpose: We aimed to evaluate the possible risk factors for the development of retinopathy of prematurity(ROP) Patients and Methods: A retrospective study was conducted between January 2012- and May 2013 for premature infants aged 34 weeks or younger who were screened for premature retinopathy. Fifty nine infants were included into the study. Birth weight, gestational age and other risk factors were evaluated.. Results: Birth weights were between 750 and 3590g (mean 1960g) gestational ages between 24 and 34weeks (mean 31.9w). ROP with various stages was observed in 7 (%11.8) patients. Birth weight and gestational age were found to be inversely related to the presence of ROP. Continuous positive airway pressure, blood transfusions were directly related to the development of ROP . Conclusion: Increased survival rate of low gestational age and low birth weights infants with better standards in neonatal intensive care units, the incidence of ROP. Efficient screening and treatment must be used to prevent the permanent visual loss associated with ROP

Anahtar Kelimeler

• Retinopathy of prematurity, birth weight, gestational age, risk factors

Premature Retinopatisi Taraması Yapılan Elli Dokuz Bebeğin Retrospektif Değerlendirilmesi

Öz

Amaç: Prematürite retinopatisi (PR) gelişimi için muhtemel risk faktörlerini değerlendirmek amaçlandı Gereç ve Yöntem: Ocak 2012-Mayıs 2013 arasında 34.gestasyonel haftasında veya daha küçük olan prematüre bebekler retrospektif olarak değerlendirildi. 59 bebek çalışma kapsamına alındı. PR gelişimi ile doğum ağırlığı, gestasyonel yaş ve diğer risk faktörleri arasındaki ilişki araştırıldı. Bulgular: Olguların doğum ağırlıkları ise 750-3590gr (ortalama 1960gr) gestasyonel yaşları 24-34hafta(ortalama 31.9hafta) arasındaydı. Çeşitli evrelerde PR, 59 bebeğin 7sinde (%11.8)saptandı. Doğum ağırlığı ve gestasyonel yaş ile PR gelişimi açısından ters orantı tespit edildi. Sürekli pozitif havayolu basıncı ile oksijen kullanımı, kan transfüzyonu gibi risk faktörleri ile PR arasında istatistiksel olarak anlamlı bir ilişki bulundu. Sonuç: Yenidoğan ünitelerindeki koşulların iyileşmesi ile birlikte bebeklerin yaşam şanslarının artması PR görülme sıklığını arttırmaktadır. Prematür retinopatisinin neden olduğu kalıcı görme kayıplarının önlenmesi için etkin takip ve tedavinin yapılması gerekmektedir

Anahtar Kelimeler

• Prematüre retinopatisi, doğum ağırlığı, doğum haftası, risk faktörleri

Kaynakça

1. 1. Arsan S. Premature retinopatisi. T Klin pediatri 2004;2: 382-6
2. 2. Hutcheson KA.: Retinopathy of Prematurity. Curr Opin Ophthalmol 2003; 14: 286-290
3. 3. Terry TL. Extreme prematurity and fibroplastic over-growth of the persistant vascular sheath behind the crystalling lens. Am J Opthalmol 1942; 25: 203-4
4. 4. Onofrey CB, Feuer WJ, Flynn JT. The outcome of retinopathy of prematurity: screening for retinopathy of prematurity using on outcome predictive programme. Ophtalmology 2001; 108: 27-34
5. 5. Shohat M, Reisner SH, Kricler R.et al.: Retinopathy of prematurity: incidence and risk factors. Pediatrics 1983; 72: 159-163
6. 6. Hussain N, Clive J, Bhandari V,Current incidence of retinopathy of prematurity. 1989-1997, Pediatrics 1999; 104(3): e26
7. 7. An international classification of retinopathy of prematurity. The Committee fort he Classification of Retinopathy of Prematurity. Arch Ophthalmol 1984;102: 1130-1134
8. 8. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723- 1729.

9. 9. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of the subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J. Pediatr 1978; 92: 529-534
10. 10. Lucey JF, Dangman B. A reexamination of the role of oxygen in retrolental fibroplasia. Pediatrics 1984; 73: 82-96
11. 11. Mutlu FM, Altınsoy HI, Mumcuoğlu T, Kerimoğlu H, Kılıç S, Kul M, Sarıcı SU, Alpay F. Screening for retinopathy of prematurity in a tertiary care newborn unit in Turkey: frequency, outcomes and risk factor analysis. J Pediatr Ophtahlmol Srabismus 2008; 45(5): 291-8
12. 12. Hussain N, Clive J, Bhandari V,Current incidence of retinopathy of prematurity. 1989-1997, Pediatrics 1999; 104(3): e26
13. 13. Akkoyun I, Oto S, Yilmaz G, Gurakan B, Tarcan A, Anuk D, et al. Risk Factors in the Development of Mild and Severe Retinopathy of Prematurity. Journal of American Association for Pediatric Ophthalmology and Strabismus. 2006;10(5):449-53.
14. 14. Rowlands E, Ionides AC, Chinn S, Mackinnon H, Davey CC. Reduced incidence of retinopathy of prematurity. Br J Ophthalmol 2001; 85(8): 933-5
15. 15. Hussain N, Clive J, Bhandari V. Current incidence of retinopathy of prematurity 1989-1997, Pediatrics 1999;104(3):e26
16. 16. Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2001; (2)
17. 17. Dani C, Reali MF, Bertini GG.. The role of blood transfusions and iron intake on retinopathy of prematurity. Early Human Development 2001; 62: 57-63
18. 18. Akisu M, Tuzun S, Arslanoglu S, Yalaz M, Kültürsay N. Effect of recombinant human erythropoietin administration on lipid peroxidation and antioxidant enzyme(s) activities in preterm infants. Acta Med Okayama 2001; 55(6): 357-62
19. 19. Gilbert C, Fielder A, Gordillo L. International NO-ROP Group. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate and high leves of development: implications for screenin programs Pediatrics 2005; 115: e518-e525
20. 20. Report of a Joint Working Party the Royal Collage of Ophtalmologists and the British Association of Perinatal Medicine. Retinopathy of prematurity: guideline for screening and treatment. Early Hum Dev 1996; 46:239-58.
21. 21. Erdeve ve ark. Restricted unıversal guidelines for ROP screening: A possible misguidance for middle income countries. Turk J Med Sci 2010; 40 (5): 791-796
22. 22. Tood DA, Wright A, Smith J, NICUS Group, Severe retinopathy of prematurity in infants <30weeks gestation in New South Wales and the Australian Capital Territo